Lobectomy Versus Segmentectomy for Early-Stage Non-small Cell Lung Cancer: Is Less More?

Affiliations

¹ Department of Thoracic Surgery, Vanderbilt University Medical Center, Nashville, USA.
² Department of Thoracic Surgery, Vanderbilt University Medical Center, Nashville, USA. caitlin.demarest@vumc.org.

Editorial

Kevin McGann et al. Ann Surg Oncol. 2024 Dec.

. 2024 Dec;31(13):8498-8500.

doi: 10.1245/s10434-024-15883-9. Epub 2024 Jul 30.

¹ Department of Thoracic Surgery, Vanderbilt University Medical Center, Nashville, USA.
² Department of Thoracic Surgery, Vanderbilt University Medical Center, Nashville, USA. caitlin.demarest@vumc.org.

No abstract available

References

1. Ginsberg RJ, Rubinstein LV. Randomized trial of lobectomy versus limited resection for T1 N0 non-small cell lung cancer. Lung Cancer Study Group. Ann Thor Surg. 1995;60:615–22. - DOI
1. Whitson BA, Groth SS, Andrade RS, et al. Survival after lobectomy versus segmentectomy for stage I non-small cell lung cancer: a population-based analysis. Ann Thor Surg. 2011;92(6):1943–50. - DOI
1. Xiang Y, Zhou K, Fang C, Han W. Impact of tumor size and differentiation grade on survival after lobectomy and segmentectomy for patients with early-stage lung adenocarcinoma. Ann Surg Oncol. 2024. https://doi.org/10.1245/s10434-024-15673-3 . - DOI - PubMed
1. Altorki N, Wang X, Kozono D, et al. Lobar or sublobar resection for peripheral stage IA non–small-cell lung cancer. New Engl J Med. 2023;388(6):489–98. - DOI - PubMed
1. Saji H, Okada M, Tsuboi M, et al. Segmentectomy versus lobectomy in small-sized peripheral non-small-cell lung cancer (JCOG0802/WJOG4607L): a multicentre, open-label, phase 3, randomised, controlled, non-inferiority trial. Lancet (British edition). 2023;399(10335):1607–17.